Review  

The place for short-acting opioids: special emphasis on remifentanil

Wolfram Wilhelm, Sascha Kreuer Critical Care 2008, 12(Suppl 3):S5 (14 May 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review  

Medications for analgesia and sedation in the intensive care unit: an overview

Diederik Gommers, Jan Bakker Critical Care 2008, 12(Suppl 3):S4 (14 May 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research  

Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial

Bernd Muellejans, Thomas Matthey, Joachim Scholpp, Markus Schill Critical Care 2006, 10:R91 (15 June 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research  

Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497]

Des Breen, Andreas Karabinis, Manu Malbrain, Rex Morais, Sven Albrecht, Inge-Lise Jarnvig, Pauline Parkinson, Andrew JT Kirkham Critical Care 2005, 9:R200-R210 (15 March 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research  

Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]

Andreas Karabinis, Kostas Mandragos, Spiros Stergiopoulos, Apostolos Komnos, Jens Soukup, Ben Speelberg, Andrew JT Kirkham Critical Care 2004, 8:R268-R280 (28 June 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Commentary  

Remifentanil for analgesia-based sedation in the intensive care unit

Ralf Kuhlen, Christian Putensen Critical Care 2004, 8:13-14 (17 December 2003)

Abstract | Full text | PDF | PubMed